Barclays’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.45M Buy
+300,100
New +$4.48M ﹤0.01% 2458

Other funds holding ALHC

Barclays's ALHC Position: Q3 2026 in Review

Barclays increased its Alignment Healthcare (ALHC) stake by 795% in Q3 2026, buying an estimated $12.5M and bringing the position to 940,243 shares worth $7.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

Barclays first reported a position in ALHC in Q1 2022 and has held it in 19 quarters since. The position peaked at $31M in Q2 2025. 118 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • Barclays held 940,243 shares of Alignment Healthcare worth $7.67M as of Q3 2026.
  • Barclays bought 835,162 Alignment Healthcare shares in Q3 2026, an estimated $12.5M.
  • Alignment Healthcare made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1806 holding.
  • Barclays first reported a position in Alignment Healthcare in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Alignment Healthcare position peaked at $31M in Q2 2025.
  • 118 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.